| abstract |
A method and assay for determining a neurological condition in a subject, whereby the level of one or more neuroactive biomarkers in a sample obtained from the subject is measured. provide. Methods and assays measure multiple neuroactive biomarkers for cooperative determination of neurological conditions such as injury, disease, contact with compounds, or neurological damage due to other causes As the first neuroactive biomarker, UCH-L1, GFAP, NSE, NeuN, CNPase, CAM-1, iNOS, MAP-1, MAP-2, SBDP145, SBDP120, βIII-tubulin, Includes synaptic protein, neuroserpin, α-internexin, LC3, neurofacin, EAAT, DAT, nestin, cortin-1, CRMP, ICAM-1, ICAM-2, ICAM-5, VCAM-1, NCAM-1, etc. . [Selection figure] None |